Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|April 7, 2022
Diabetes Technology Myths & Facts for Primary Care Practitioners
Author(s)Grace Halsey
Initiating diabetes technology of any kind is a big step for patients, but also for a lot of primary care clinicians. If you have concerns, these myths and facts are for you.
Advertisement
Diabetes "technology," ie, medication delivery and glucose monitoring devices, can benefit any patient with diabetes. Available devices range from test strip- based glucose monitors and injectable medication pens to Bluetooth enabled continuous glucose monitors and insulin pumps.
Do you think about getting patients started using a device but recall having "heard a few things" that make you hesitate?
Click through the myths/concerns below and the facts on diabetes tech, compiled by Diabeteswise.org , and find a comment from a clinican who treates diabetes patients to help dispel each concern.
Advertisement
Related to this article
Evolocumab was associated with a 20% lower risk of fatal or nonfatal myocardial infarction than ezetimibe among more than 544 000 adults with ASCVD.
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
Greater Mediterranean diet adherence was associated with lower odds of adult acne, particularly among women, in a UK Biobank study of dietary patterns.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
October FDA news included updates on long-acting olanzapine, multi-cancer blood testing, stroke rehabilitation, and heart failure monitoring.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Cheryl Cox Kinney, MD, explains when night sweats warrant further evaluation, including red flags, persistent symptoms, and potential nonmenopausal causes.
Advertisement
Advertisement